Capability
Your brand on the pack, made in India
Third-party veterinary manufacturing is the most searched-for service in Indian animal health and the most casually promised. It works well when the volumes are real and the regulatory path is clear. Here is what it takes.
Who this actually suits
Distributors with an established route to market who are tired of competing on price for the same brands as everyone else. Veterinary chains that want a house range. Government tender participants who need a specific pack and a specific price point. Feed companies adding a supplement line.
It suits you badly if you are testing a market. The economics only work above the manufacturer's minimum batch, and holding twenty thousand units of an unproven line in a market you do not yet understand is an expensive way to learn something you could have learned with a stocked product.
How it runs
- You brief the product: molecule, strength, presentation, pack size, target price and market.
- We match it to a plant and send an indicative costing with the minimum batch.
- Samples of the standard formulation go out for your evaluation, typically a week by courier.
- Artwork: you supply brand assets, we handle the mandatory text block for the destination and send a proof.
- Regulatory review of the artwork in the destination market, by your agent. This step is not optional.
- Purchase order and advance payment. Production is scheduled against the plant's batch calendar.
- Production, in-process checks and finished product release with a batch Certificate of Analysis.
- Pre-shipment photographs, then export on our documentation as with any other order.
Minimum batches and what it costs
Unit cost on a private-label run usually lands somewhere between ten and twenty-five percent below the equivalent branded product, because you are not paying for someone else's brand. Against that, you are carrying the inventory, the artwork origination and the registration.
| Presentation | Minimum batch | Artwork origination | Production |
|---|---|---|---|
| Oral liquid | 10,000 units | From $180 per SKU | 30 to 40 days |
| Tablet / capsule | 20,000 packs | From $220 per SKU | 35 to 45 days |
| Topical / spot-on | 10,000 units | From $250 per SKU | 35 to 50 days |
| Powder / sachet | 500 kg | From $160 per SKU | 25 to 35 days |
| Injection | 5,000 vials | From $300 per SKU | 45 to 60 days |
| Feed premix | 2 metric tonnes | From $140 per SKU | 25 to 35 days |
Artwork origination is charged at cost and credited against the first production order. Production time starts when artwork is approved and payment is received, not when the enquiry arrives.
Who is responsible for what
- Manufacturer: formulation, production to GMP, batch release, Certificate of Analysis, stability data
- Us: sourcing, qualification, artwork coordination, quality oversight, export documentation, logistics
- You: brand assets, artwork approval, registration in the destination, local regulatory compliance, market-side pharmacovigilance
A realistic timeline
Brief to samples, two weeks. Samples to approved artwork, three to five weeks, and this is where projects slip because regulatory review in the destination takes as long as it takes. Artwork to finished goods, four to eight weeks depending on presentation. Then shipping.
Three to five months from first conversation to goods in your warehouse is normal, and that assumes the product is already registrable in your market. If it needs a new registration, add the registration timeline on top, and plan the two in parallel rather than in sequence.
Common questions
What is the minimum order for private label veterinary products?
+
It is set by the manufacturer's batch size, not by us. Oral liquids typically start around 10,000 units, tablets around 20,000 packs, injectables around 5,000 vials and premix at 2 metric tonnes. Below that, buying a stocked product and relabelling it where the destination permits is usually the better commercial answer.
Can I start with one product?
+
You can, and most people should. A single well-chosen line proves the supply chain, the artwork process and the registration route before you commit to a range. Launching eight products at once means eight simultaneous registration files and one very large first invoice.
Who owns the formulation?
+
For a standard generic formulation, the manufacturer does, and so will everyone else selling the same thing. If you want exclusivity you are asking for a developed formulation with a defined territory, which is a different commercial conversation and usually involves a development fee and a volume commitment.
Do I need to register the product in my own name?
+
In most markets, yes, and that is the point of private label. The registration is held by you or your local agent, which means the brand and the market position stay with you rather than with the supplier.